Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • give logo Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Call for Abstracts
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • Dates and Deadlines
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Guidelines for Participating in SfN Events
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2024 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Attend
      • Read
      • Watch
      • Listen
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Diversity Initiatives
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
131 - 140 of 890 results
  • Abstract
    Effect of prenatal nicotine and THC on cognitive behaviours in adolescent male and female rats.
    Although there has been a decrease in the prevalence of tobacco smoking in many developed countries, exposure to nicotine/tobacco during pregnancy remains a substantial problem worldwide. Further, given the recent escalation in e-cigarette use among var...
    Nov 9, 2021
  • Abstract
    Cannabidiol administration significantly improves social behavior and increases seizure resistance in an Scn8a mouse model
    An increasing number of de novo SCN8A mutations have been identified in patients with catastrophic, treatment-resistant childhood epilepsy. De novo SCN8A mutations have also been found in patients with autism, intellectual disability and developmental d...
    Nov 9, 2021
  • High-THC Cannabis Smoke Impairs Incidental Memory Capacity in Spontaneous Tests of Novelty Preference for Objects and Odors in Male Rats | eNeuro
    Working memory is an executive function that orchestrates the use of limited amounts of information, referred to as working memory capacity, in cognitive functions. Cannabis exposure impairs working memory in humans; however, it is unclear whether Cannabis facilitates or impairs rodent working memory and working memory capacity. The conflicting literature in rodent models may be at least partly because of the use of drug exposure paradigms that do not closely mirror patterns of human Cannabis use. Here, we used an incidental memory capacity paradigm where a novelty preference is assessed after a short delay in spontaneous recognition-based tests. Either object or odor-based stimuli were used in test variations with sets of identical [identical stimuli test (IST)] and different [different stimuli test (DST)] stimuli (three or six) for low-memory and high-memory loads, respectively. Additionally, we developed a human-machine hybrid behavioral quantification approach which supplements stopwatch-based scoring ...
    Dec 1, 2023 Ilne L. Barnard
  • Abstract
    Chronic marijuana users show altered behavioral and neural response to monetary loss
    Chronic marijuana use has been associated with the inability to develop successful decision-making strategies during performance of the Iowa Gambling Task (IGT) (Whitlow et al., 2004). Because the IGT is a highly complex task that includes motivational ...
    Nov 6, 2007
  • Abstract
    Chronic thc exposure: effects on sucrose conditioned place preference in adolescent rats
    The psychoactive constituent in marijuana Δ9-tetrahydrocannabinol (THC) pharmacologically activates the mesolimbic reward pathways (Gardner, 2005). Similarly highly palatable foods also activate the reward circuitry of the brain (Volkow and Wise, 2005)....
    Nov 6, 2007
  • Abstract
    The effects of cannabidiol in a kainate model of temporal lobe epilepsy.
    Cannabinoids, including cannabidiol (CBD), a non-psychoactive component of cannabis sativa, have been shown to exhibit anticonvulsant properties in animal models of epilepsy (Wallace et al. 2001; 2003). To investigate cannabinoid-mediated seizure control, CBD was compared to the synthetic CB1 receptor agonist HU-210 in a rat model of kainate-induced temporal lobe seizures (TLS) in vivo. Multiple single-unit and local field potentials (LFPs) were recorded from the hippocampus of male Sprague Dawley rats (200-300g) anaesthetised with urethane (1.3g kg-1 i.p.) or isoflurane/N2O/O2 using 16-channel micro-wire electrodes (NB Labs) and a Plexon Map system. Kainate (KA: 10mg kg-1), cannabidiol (10 or 40mg kg-1) or HU-210 (100μg kg-1) were administered i.p. Data was analysed with Neuroexplorer, including firing frequency, burst analysis, T50 for KA-induced effects, and LFP power spectral density (PSD). While CBD reduced basal firing in ∼20% of cells, CBD did not alter KA-induced firing administered before (n=63 ce...
    Nov 15, 2005
  • Meetings Neuroscience Quarterly
    Gear Up for Neuroscience 2016: Science, Learning, Networking
    Join your peers at SfN’s 46th annual meeting to explore emerging science, hear from renowned experts, develop your career, and collaborate.
  • Abstract
    Differences in regional brain function due to marijuana use by methamphetamine abusers.
    Most studies of human drug abuse highlight dependence on one primary agent without explicitly considering use of other psychoactive agents such as marijuana (MJ). We previously showed regional cerebral dysfunction in methamphetamine (MA) abusers, particularly in limbic/paralimbic areas, and now assess the combined effects of MJ and MA on cerebral function. We studied 14 MA abusers who reported MA as their drug of choice, had on average used MA for >8 years, and used it on most of the 30 days prior to entering the study. We separated this sample into one group of subjects who reported no substantial drug use other than MA abuse (-MJ, n=7), and another group of subjects who either used MJ frequently (>1 joint/wk) or met DSM-IV criteria for THC dependence (+MJ,n=7). Both groups abstained from all illicit drug use for 5–11 days before assay of global and regional cerebral glucose metabolism (CMRglc, rCMRglc) with PET during performance of an attentional task. The +MJ group had 6% lower CMRglc than the -MJ grou...
    Nov 10, 2003
  • Abstract
    Previous exposure to δ9-THC does not promote the pursuit of amphetamine.
    Rats previously exposed to amphetamine (AMPH) show enhanced locomotor and nucleus accumbens (NAcc) dopamine (DA) responding to the drug as well as enhanced self-administration of AMPH and cocaine. The present experiments assessed the effects of pre-exposing rats to Δ9-THC. Rats in different groups were given five pre-exposure injections of saline or one of five doses of Δ9-THC (0.4, 0.75, 1.5, 3.0, 6.0 mg/kg, IP), one injection every third day, and tested two to three weeks later. Previous exposure to all but the lowest dose of Δ9-THC enhanced the locomotor response to AMPH (0.75 mg/kg, IP) but all failed to enhance NAcc DA overflow in response to AMPH. Previous exposure to 3.0 mg/kg (IP, the most effective Δ9-THC dose above) also enhanced forskolin-evoked adenylyl cyclase activity in the NAcc and rats’ locomotor response to the direct DA receptor agonist apomorphine (1.0 mg/kg, SC), suggesting that previous exposure to Δ9-THC enhances locomotor responding to AMPH by up-regulating postsynaptic DA receptor ...
    Nov 8, 2003
  • Abstract
    Cannabidiol elevates the ratio of feedforward to feedback inhibition to dampen hippocampal activity propagation
    Cannabis sativa L. derivatives are emerging as therapeutics for some forms of epilepsy, with one formulation being FDA approved (Devinsky et al., 2017, 2018). Cannabidiol (CBD) administration to patients with certain treatment-resistant epilepsies signi...
    Oct 23, 2019
  • Previous
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next

Featured

  • Watch: The Inspiration Behind the Neuroscience 2025 Logo
  • Upcoming Webinar: JNeurosci Town Hall
  • Find a Roommate for Neuroscience 2025 in the Roommate Matching Forum
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience